Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome

Journal of the Neurological Sciences

Volumn 220, Issue 1-2, 2004, Pages 59-66

  Wang, Xinsheng ^a   Wiesinger, Jason ^b   Beard, John ^b   Felt, Barbara ^c   Menzies, Sharon ^a   Earley, Christopher ^d   Allen, Richard ^d   Connor, James ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; central nervous system; CNS; deferoxamine mesylate; DFO; Dopamine; horseradish peroxidase; HRP; ID; iron deficient; nerve growth factor; NGF; OD; optical density; PBS; PC12; PC12 cells; phosphate buffered saline; Sleep disorders; Substantia nigra

Indexed keywords

IRON; THY 1 ANTIGEN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BRAIN HOMOGENATE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; IRON CHELATION; IRON DEFICIENCY; IRON RESTRICTION; MALE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, THY-1; BLOTTING, WESTERN; CELL COUNT; DEFEROXAMINE; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IRON; IRON CHELATING AGENTS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; RATS; RECEPTORS, TRANSFERRIN; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 2442553766     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.02.004     Document Type: Article

References (39)

1. Reif A.E., Allen J.M. Mouse thymic iso-antigens. Nature. 209:1966;521-523
2. Morris R.J., Beech J.N., Barber P.C., Raisman G. Early stages of Purkinje cell maturation demonstrated by Thy-1 immunohistochemistry on postnatal rat cerebellum. J. Neurocytol. 14:1985;427-452
3. Seki M., Nawa H., Morioka T., Fukuchi T., Oite T., Abe H., et al. Establishment of a novel enzyme-linked immunosorbent assay for Thy-1; quantitative assessment of neuronal degeneration. Neurosci. Lett. 329:2002;185-188
4. Jeng C.J., McCarroll S.A., Martin T.F., Floor E., Adams J., Krantz D., et al. Thy-1 is a component common to multiple populations of synaptic vesicles. J. Cell Biol. 140:1998;685-698
5. Almqvist P., Carlssoon S.R., Hardy J.A., Winblad B. Regional and subcellular distribution of Thy 1 in human brain assayed by solid phase radioimmunoassay. J. Neurochem. 46:1986;681-686
6. Shults C.W., Kimber T.A. Thy-1 immunoreactivity distinguishes patches/striosomes from matrix in the early postnatal striatum of the rat. Brain Res. Dev. Brain Res. 75:1993;136-140
7. Fishell G., van der Kooy D. Pattern formation in the striatum: developmental changes in the distribution of striatonigral neurons. J. Neurosci. 7:1987;1969-1978
8. van der Kooy D., Fishell G. Neuronal birthdate underlies the development of striatal compartments. Brain Res. 401:1987;155-161
9. Voorn P., Kalsbeek A., Jorritsma-Byham B., Groenewegen H.J. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience. 25:1988;857-887
10. Nosten-Bertrand M., Errington M.L., Murphy K.P.S.J., Tokugawa Y., Barboni E., Kozlova E., et al. Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature. 379:1996;826-829
11. Ye Z., Connor J.R. Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res. 28:2002;1802-1807
12. Beard J.L., Connor J.R. Iron status and neural functioning. Annu. Rev. Nutr. 23:2003;41-58. [electronic publication 2003 Apr. 10]
13. Ward R.J., Dexter D., Florence A., Aouad F., Hider R., Jenner P., et al. Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism. Biochem. Pharmacol. 49:1995;1821-1826
14. Hill J.M. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA. Brain Res. 342:1985;18-25
15. Earley C.J., Allen R.P., Beard J.L., Connor J.R. Insight into the pathophysiology of restless legs syndrome. J. Neurosci. Res. 62:2000;623-628
16. Allen R.P., Barker P.B., Wehrl F., Song H.K., Earley C.J. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 56:2001;263-265
17. Connor J.R., Boyer P.J., Menzies S.L., Dellinger B., Allen R.P., Earley C.J. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 61:2003;304-309
18. Montplaisir J., Lorrain D., Godbout R. Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanisms. Eur. Neurol. 31:1991;41-43
19. Earley C.J., Connor J.R., Beard J.L., Malecki E.A., Epstein D.K., Allen R.P. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 54:2000;1698-1700
20. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73(7):1976 (Jul.);2424-2428
21. Provoda C.J., Waring M.T., Buckley K.M. Evidence for a primary endocytic vesicle involved in synaptic vesicle biogenesis. J. Biol. Chem. 275:2000;7004-7012
22. Allen R., Hening W., Montplaisir J., Picchietti D., Trenkwalder C., Walters A.S., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med. 4:2003;101-119
23. Caillaud T., Opstal W.Y., Scarceriaux V., Billardon C., Rostene W. Treatment of PC12 cells by nerve growth factor, dexamethasone, and forskolin. Effects on cell morphology and expression of neurotensin and tyrosine hydroxylase. Mol. Neurobiol. 10:1995;105-114
24. Doherty P., Walsh F.S. Control of Thy-1 glycoprotein expression in cultures of PC12 cells. J. Neurochem. 49:1987;610-616
25. Eisenstein R.S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr. 20:2000;627-662
26. Beard J.L., Erikson K.M., Jones B.C. Neurobehavioral analysis of developmental iron deficiency in rats. Behav. Brain Res. 134:2002;517-524
27. Erikson K.M., Jones B.C., Hess E.J., Zhang Q., Beard J.L. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol. Biochem. Behav. 69:2001;409-418
28. Connor J.R., Wang X.S., Patton S.M., Menzies S.L., Troncoso J.C., Earley C.J., et al. Decreased transferrin receptor expression by neuromelanin cells in Restless Legs Syndrome. Neurology. 2004;. in press
29. Chesson A.L., Wise M., Davila D., Johnson S., Littner M., Anderson W.M., et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 22:1999;962-968
30. Hening W., Allen R., Earley C., Kushida C., Picchietti D., Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 22:1999;970-999
31. Ekbom K.A. Restless legs syndrome. Neurology. 10:1960;868-873
32. Blom S., Ekbom K.A. Comparison between akathisia developing on treatment with phenothiazine derivatives and the restless legs syndrome. Acta Med. Scand. 170:1961;689-694
33. Ratey J.J., Salzman C. Recognizing and managing akathisia. Hosp. Community Psychiat. 35:1984;975-977
34. Hollrigel G.S., Morris R.J., Soltensz I. Enhanced inhibitory charge transfer during bursts of IPSCs in dentate granule cells in mice with regionally inhibited LTP. Proc. R. Soc. Lond., B. 265:1998;63-69
35. Taneja V., Mishra K., Agarwal K.N. Effect of early iron deficiency in rat on the gamma-aminobutyric acid shunt in brain. J. Neurochem. 46:1986;1670-1674
36. Taneja V., Mishra K.P., Agarwal K.N. Effect of maternal iron deficiency on GABA shunt pathway of developing rat brain. Indian J. Exp. Biol. 28:1990;466-469
37. Shukla A., Agarwal K.N., Shukla G.S. Latent iron deficiency alters gamma-aminobutyric acid and glutamate metabolism in rat brain. Experientia. 45:1989;343-345
38. Agarwal K.N. Iron and the brain: neurotransmitter receptors and magnetic resonance spectroscopy. Br. J. Nutr. 85(Suppl. 2):2001;S147-S150
39. Sastry S., Arendash G.W. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience. 67:1995;649-666